Neuropsychopharmacology - Table of Contents alert Volume 42 Issue 9

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 42, Issue 9 (August 2017) In this issue Commentary Review Original Articles Corrigenda Facebook Twitter Sign up for e-alerts Recommend to your library Web feed Subscribe Commentary Top Strained in Planning Your Mouse Background? Using the HPA Stress Axis as a Biological Readout for Backcrossing Strategies Jennifer C Chan, Amanda B Houghton and Tracy L Bale Neuropsychopharmacology 2017 42: 1749-1751; advance online publication, March 31, 2017; 10.1038/npp.2017.66 Full Text Review Top Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis Suzanne Nielsen, Pamela Sabioni, Jose M Trigo, Mark A Ware, Brigid D Betz-Stablein, Bridin Murnion, Nicholas Lintzeris, Kok Eng Khor, Michael Farrell, Andrew Smith and Bernard Le Foll Neuropsychopharmacology 2017 42: 1752-1765; advance online publication, March 22, 2017; 10.1038/npp.2017.51 Abstract | Full Text Original Articles Top Methylphenidate and Memory and Attention Adaptation Training for Persistent Cognitive Symptoms after Traumatic Brain Injury: A Randomized, Placebo-Controlled Trial Brenna C McDonald, Laura A Flashman, David B Arciniegas, Robert J Ferguson, Li Xing, Jaroslaw Harezlak, Gwen C Sprehn, Flora M Hammond, Arthur C Maerlender, Carrie L Kruck, Karen L Gillock, Kim Frey, Rachel N Wall, Andrew J Saykin and Thomas W McAllister Neuropsychopharmacology 2017 42: 1766-1775; advance online publication, November 22, 2016; 10.1038/npp.2016.261 Abstract | Full Text Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial Lara A Ray, Spencer Bujarski, Steve Shoptaw, Daniel JO Roche, Keith Heinzerling and Karen Miotto Neuropsychopharmacology 2017 42: 1776-1788; advance online publication, January 16, 2017; 10.1038/npp.2017.10 Abstract | Full Text The GABAB Positive Allosteric Modulator ADX71441 Attenuates Alcohol Self-Administration and Relapse to Alcohol Seeking in Rats Eric Augier, Russell S Dulman, Ruslan Damadzic, Andrew Pilling, J Paul Hamilton and Markus Heilig Neuropsychopharmacology 2017 42: 1789-1799; advance online publication, March 15, 2017; 10.1038/npp.2017.53 Abstract | Full Text Ethanol Dependence Abolishes Monoamine and GIRK (Kir3) Channel Inhibition of Orbitofrontal Cortex Excitability Sudarat Nimitvilai, Marcelo F Lopez, Patrick J Mulholland and John J Woodward Neuropsychopharmacology 2017 42: 1800-1812; advance online publication, January 31, 2017; 10.1038/npp.2017.22 Abstract | Full Text Ethanol Withdrawal Drives Anxiety-Related Behaviors by Reducing M-type Potassium Channel Activity in the Lateral Habenula Seungwoo Kang, Jing Li, Wanhong Zuo, Rao Fu, Danielle Gregor, Kresimir Krnjevic, Alex Bekker and Jiang-Hong Ye Neuropsychopharmacology 2017 42: 1813-1824; advance online publication, April 7, 2017; 10.1038/npp.2017.68 Abstract | Full Text Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid Dependence Verena E Metz, Jermaine D Jones, Jeanne Manubay, Maria A Sullivan, Shanthi Mogali, Andrew Segoshi, Gabriela Madera, Kirk W Johnson and Sandra D Comer Neuropsychopharmacology 2017 42: 1825-1832; advance online publication, April 10, 2017; 10.1038/npp.2017.70 Abstract | Full Text Opioid Modulation of Value-Based Decision-Making in Healthy Humans Marie Eikemo, Guido Biele, Frode Willoch, Lotte Thomsen and Siri Leknes Neuropsychopharmacology 2017 42: 1833-1840; advance online publication, March 15, 2017; 10.1038/npp.2017.58 Abstract | Full Text Sex Differences in Regional Brain Glucose Metabolism Following Opioid Withdrawal and Replacement Giovanni C Santoro, Joseph Carrion, Krishna Patel, Crystal Vilchez, Jennifer Veith, Jonathan D Brodie and Stephen L Dewey Neuropsychopharmacology 2017 42: 1841-1849; advance online publication, April 10, 2017; 10.1038/npp.2017.69 Abstract | Full Text High-Frequency Stimulation of the Subthalamic Nucleus Blocks Compulsive-Like Re-Escalation of Heroin Taking in Rats Carrie L Wade, Marsida Kallupi, Daniel O Hernandez, Emmanuel Breysse, Giordano de Guglielmo, Elena Crawford, George F Koob, Paul Schweitzer, Christelle Baunez and Olivier George Neuropsychopharmacology 2017 42: 1850-1859; advance online publication, December 5, 2016; 10.1038/npp.2016.270 Abstract | Full Text Glutamatergic Projections from the Entorhinal Cortex to Dorsal Dentate Gyrus Mediate Context-Induced Reinstatement of Heroin Seeking OPEN Feifei Ge, Na Wang, Cailian Cui, Yijing Li, Yan Liu, Yaoying Ma, Shuli Liu, Haolin Zhang and Xiaowei Sun Neuropsychopharmacology 2017 42: 1860-1870; advance online publication, January 20, 2017; 10.1038/npp.2017.14 Abstract | Full Text The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic Hai-Ying Zhang, Guo-Hua Bi, Hong-Ju Yang, Yi He, Gilbert Xue, Jiajing Cao, Gianluigi Tanda, Eliot L Gardner, Amy Hauck Newman and Zheng-Xiong Xi Neuropsychopharmacology 2017 42: 1871-1883; advance online publication, March 7, 2017; 10.1038/npp.2017.41 Abstract | Full Text Garcinol Blocks the Reconsolidation of Multiple Cocaine-Paired Cues after a Single Cocaine-Reactivation Session Amber B Dunbar and Jane R Taylor Neuropsychopharmacology 2017 42: 1884-1892; advance online publication, February 7, 2017; 10.1038/npp.2017.27 Abstract | Full Text Cocaine Potency at the Dopamine Transporter Tracks Discrete Motivational States During Cocaine Self-Administration Cody A Siciliano and Sara R Jones Neuropsychopharmacology 2017 42: 1893-1904; advance online publication, January 31, 2017; 10.1038/npp.2017.24 Abstract | Full Text Associations Between Behavioral and Neural Correlates of Inhibitory Control and Amphetamine Reward Sensitivity Jessica Weafer, Stephanie M Gorka, Donald Hedeker, Mario Dzemidzic, David A Kareken, K Luan Phan and Harriet de Wit Neuropsychopharmacology 2017 42: 1905-1913; advance online publication, March 17, 2017; 10.1038/npp.2017.61 Abstract | Full Text A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder OPEN Daniel Umbricht, Marta del Valle Rubido, Eric Hollander, James T McCracken, Frederick Shic, Lawrence Scahill, Jana Noeldeke, Lauren Boak, Omar Khwaja, Lisa Squassante, Christophe Grundschober, Heidemarie Kletzl and Paulo Fontoura Neuropsychopharmacology 2017 42: 1914-1923; advance online publication, October 6, 2016; 10.1038/npp.2016.232 Abstract | Full Text Corrigenda Top A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder Daniel Umbricht, Marta del Valle Rubido, Eric Hollander, James T McCracken, Frederick Shic, Lawrence Scahill, Jana Noeldeke, Lauren Boak, Omar Khwaja, Lisa Squassante, Christophe Grundschober, Heidemarie Kletzl and Paulo Fontoura Neuropsychopharmacology 2017 42: 1924; 10.1038/npp.2017.92 Full Text Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence Anna Murphy, Liam J Nestor, John McGonigle, Louise Paterson, Venkataramana Boyapati, Karen D Ersche, Remy Flechais, Shankar Kuchibatla, Antonio Metastasio, Csaba Orban, Filippo Passetti, Laurence Reed, Dana Smith, John Suckling, Eleanor Taylor, Trevor W Robbins, Anne Lingford-Hughes, David J Nutt, John F W Deakin, Rebecca Elliott and ICCAM Platform Neuropsychopharmacology 2017 42: 1925-1926; 10.1038/npp.2017.99 Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.